Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 5, 2011

View Archived Issues

Preclinical and clinical phase I/II data presented on GSK-573719 for COPD

Novel SMYD2 inhibitor identified at AstraZeneca

Novel pan-Aurora kinase inhibitor is active against drug-resistant cancer cells

Novel CO-releasing rhenium complexes developed at Swiss university

Phosphagenics to advance development of twice-weekly oxycodone patch

Enrollment complete in pediatric Xerecept trial

Incozen Therapeutics describes new PI3K-delta inhibitor

Creabilis raises funds for development of CT-327

Scientists at GSK prepare new lysophospholipid S1P1 receptor agonists

Novel neuroprotective agents patented

New saRNA molecules claimed by University of California scientists

Novel PP1 inhibitors synthesized

EntreMed reports encouraging phase II results on ENMD-2076

Fibrocell Science launches laViv in U.S.

InSite Vision releases phase II pharmacokinetic data on BromSite

Intellect Neurosciences and ViroPharma enter licensing agreement for OX-1

CalciMedica presents novel protein orai-1 inhibitors

NuPathe reports encouraging data from migraine patch trial

Gliknik receives SBIR contract to advance stradobodies

Merck Serono and Ono Pharmaceutical collaborate on MS drug and cancer vaccine

G-Zero Therapeutics receives NIH grant for studies in radiation exposure

Karo Bio enrolls first patient in AKKA study

Neurocrine and Abbott reach second milestone in elagolix collaboration

First patients dosed with Xiaflex in Dupuytren's contracture multicord study

Cariprazine study meets primary endpoint

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...